Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- bài báo khoa học (vi)
- наукова стаття, опублікована в листопаді 1999 (uk)
- article scientifique publié en 1999 (fr)
- im November 1999 veröffentlichter wissenschaftlicher Artikel (de)
- scientific article published on 01 November 1999 (en)
- artículu científicu espublizáu en payares de 1999 (ast)
|
publication date
| |
publication date
| |
language of work or name
| |
language of work or name
| |
author name string
| |
author name string
| - U Nowak-Göttl
- R Junker
- M Neufeld
|
rdfs:label
| - Citrate-theophylline-adenine-dipyridamol buffer is preferable to citrate buffer as an anticoagulant for flow cytometric measurement of platelet activation (en)
- Citrate-theophylline-adenine-dipyridamol buffer is preferable to citrate buffer as an anticoagulant for flow cytometric measurement of platelet activation (nl)
|
skos:prefLabel
| - Citrate-theophylline-adenine-dipyridamol buffer is preferable to citrate buffer as an anticoagulant for flow cytometric measurement of platelet activation (en)
- Citrate-theophylline-adenine-dipyridamol buffer is preferable to citrate buffer as an anticoagulant for flow cytometric measurement of platelet activation (nl)
|
name
| - Citrate-theophylline-adenine-dipyridamol buffer is preferable to citrate buffer as an anticoagulant for flow cytometric measurement of platelet activation (en)
- Citrate-theophylline-adenine-dipyridamol buffer is preferable to citrate buffer as an anticoagulant for flow cytometric measurement of platelet activation (nl)
|
title
| |
title
| - Citrate-theophylline-adenine-dipyridamol buffer is preferable to citrate buffer as an anticoagulant for flow cytometric measurement of platelet activation (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
is about
of | |
is cites work
of | |
is cites work
of | |